Shuttle Pharmaceuticals Holdings, Inc. Profile Avatar - Palmy Investing

Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropi…

Drug Manufacturers - Specialty & Generic
US, Rockville [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Shuttle Pharmaceuticals Holdings, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Shuttle Pharmaceuticals Holdings, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Shuttle Pharmaceuticals Holdings, Inc..

End of SHPH's Analysis
CIK: 1757499 CUSIP: 825693203 ISIN: US8256932034 LEI: - UEI: -
Secondary Listings
SHPH has no secondary listings inside our databases.